Somapacitan Administered Subcutaneously at 5 mg/1.5 mL or 10 mg/1.5 mL Strengths Yields Clinically Similar PK and IGF-I Profiles in Healthy Participants

Disease Areas
Congresses
Scientific Publications
IME

Register Login

My Account

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Congresses
ENDO
Somapacitan Administered Subcutaneously at 5 mg/1.5 mL or 10 mg/1.5 mL Strengths Yields Clinically Similar PK and IGF-I Profiles in Healthy Participants